✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

RemeGen Co Ltd

Common Name
RemeGen
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
2,999
Ticker
688331
Exchange
SHANGHAI STOCK EXCHANGE
Description
RemeGen Co., Ltd. is a biotechnology company focusing on the research, development, and commercialization of novel biologics for the treatment of cancer, autoimmune disorders, and other serious diseas...

Disclosures of RemeGen

Explore RemeGen's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from RemeGen's official channels and fully traceable to its official company sources.

The table below lists all of RemeGen's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across RemeGen's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
ESG Report
2024
Annual Report
2024
ESG Report
2023
Annual Report
2023
Annual Report
2022
ESG Report
2022
Annual Report
2021
Annual Report
2020
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?